Stephanie Diaz | Investor Relations |
Brian Lian | President and Chief Executive Officer |
Gregory Zante | Chief Financial Officer |
Joon So Lee | Truist Securities |
Steven Seedhouse | Raymond James & Associates |
Joseph Pantginis | H.C. Wainwright |
Andy Hsieh | William Blair |
Yale Jen | Laidlaw & Company |
Scott Henry | ROTH MKM Partners |
Justin Zelin | BTIG |
Nazibur Rahman | Maxim Group |
Welcome to the Viking Therapeutics Fourth Quarter and Full-year 2022 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
Following management’s prepared remarks, we will hold a question and answer session. [Operator Instructions] As a reminder, this conference call is being recorded today, February 8, 2023.
I would now like to turn the over to Viking’s Manager of Investor Relations, Stephanie Diaz.